Literature DB >> 15718115

Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study.

Lillian Sung1, Jill Hayden, Mark L Greenberg, Gideon Koren, Brian M Feldman, George A Tomlinson.   

Abstract

OBJECTIVE: (1) To generate a list of items that experts consider most important when reporting a Bayesian analysis of a clinical study, (2) to report on the extent to which we found these items in the literature, and (3) to identify factors related to the number of items in a report. STUDY DESIGN AND
SETTING: Based on opinions from 23 international experts, we determined the items considered most important when publishing a Bayesian analysis. We then performed a literature search to identify articles in which a Bayesian analysis was performed and determined the extent to which we found these items in each report. Finally, we examined the relationship between the number of items in a report and journal- and article-specific attributes.
RESULTS: Our final set of seven items described the prior distribution (specification, justification, and sensitivity analysis), analysis (statistical model and analytic technique), and presentation of results (central tendency and variance). There was >99% probability that more items were reported in studies with a noncontrolled study design and in journals with a methodological focus, lower impact factor, and absence of a word count limit.
CONCLUSION: We developed a set of seven items that experts believe to be most important when reporting a Bayesian analysis.

Mesh:

Year:  2005        PMID: 15718115     DOI: 10.1016/j.jclinepi.2004.08.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  34 in total

1.  Quality assessment of phase I dose-finding cancer trials: proposal of a checklist.

Authors:  Sarah Zohar; Qing Lian; Vincent Levy; Ken Cheung; Anastasia Ivanova; Sylvie Chevret
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

2.  CORR Insights®: Prediction of Postoperative Clinical Recovery of Drop Foot Attributable to Lumbar Degenerative Diseases, via a Bayesian Network.

Authors:  Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2017-01-03       Impact factor: 4.176

Review 3.  Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose.

Authors:  Jan Menke; Jörg Kowalski
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

Review 4.  The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.

Authors:  Robert B Hopkins; Ron Goeree; Eleanor Pullenayegum; Jonathan D Adachi; Alexandra Papaioannou; Feng Xie; Lehana Thabane
Journal:  BMC Musculoskelet Disord       Date:  2011-09-26       Impact factor: 2.362

5.  Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc analysis of the SUP-ICU trial.

Authors:  Anders Granholm; Søren Marker; Mette Krag; Fernando G Zampieri; Hans-Christian Thorsen-Meyer; Benjamin Skov Kaas-Hansen; Iwan C C van der Horst; Theis Lange; Jørn Wetterslev; Anders Perner; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2020-01-14       Impact factor: 17.440

6.  Reporting guidelines: optimal use in preventive medicine and public health.

Authors:  Karyn Popham; William A Calo; Melissa Y Carpentier; Naomi E Chen; Samira A Kamrudin; Yen-Chi L Le; Katherine A Skala; Logan R Thornton; Patricia Dolan Mullen
Journal:  Am J Prev Med       Date:  2012-10       Impact factor: 5.043

Review 7.  Efficacy of vitamin D supplementation in depression in adults: a systematic review.

Authors:  Guowei Li; Lawrence Mbuagbaw; Zainab Samaan; Maicon Falavigna; Shiyuan Zhang; Jonathan D Adachi; Ji Cheng; Alexandra Papaioannou; Lehana Thabane
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

Review 8.  The JASP guidelines for conducting and reporting a Bayesian analysis.

Authors:  Johnny van Doorn; Don van den Bergh; Udo Böhm; Fabian Dablander; Koen Derks; Tim Draws; Alexander Etz; Nathan J Evans; Quentin F Gronau; Julia M Haaf; Max Hinne; Šimon Kucharský; Alexander Ly; Maarten Marsman; Dora Matzke; Akash R Komarlu Narendra Gupta; Alexandra Sarafoglou; Angelika Stefan; Jan G Voelkel; Eric-Jan Wagenmakers
Journal:  Psychon Bull Rev       Date:  2021-06

9.  Comparison of Bayesian and classical methods in the analysis of cluster randomized controlled trials with a binary outcome: the Community Hypertension Assessment Trial (CHAT).

Authors:  Jinhui Ma; Lehana Thabane; Janusz Kaczorowski; Larry Chambers; Lisa Dolovich; Tina Karwalajtys; Cheryl Levitt
Journal:  BMC Med Res Methodol       Date:  2009-06-16       Impact factor: 4.615

Review 10.  Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?

Authors:  Christopher J Yarnell; Darryl Abrams; Matthew R Baldwin; Daniel Brodie; Eddy Fan; Niall D Ferguson; May Hua; Purnema Madahar; Danny F McAuley; Laveena Munshi; Gavin D Perkins; Gordon Rubenfeld; Arthur S Slutsky; Hannah Wunsch; Robert A Fowler; George Tomlinson; Jeremy R Beitler; Ewan C Goligher
Journal:  Lancet Respir Med       Date:  2020-11-20       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.